Surgical Resection for Hepatoblastoma-Updated Survival Outcomes
| Autor: | Bhanu Jayanand Sunil, Ravisankar Palaniappan, Rama Ranganathan, Balasubramanian Venkitaraman |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Hepatoblastoma
Male medicine.medical_specialty Lung Neoplasms medicine.medical_treatment Population India Malignancy Gastroenterology 03 medical and health sciences 0302 clinical medicine Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Hepatectomy Humans Stage (cooking) education Neoplasm Staging Retrospective Studies Chemotherapy education.field_of_study business.industry Liver Neoplasms Infant medicine.disease Survival Analysis Neoadjuvant Therapy Surgery Radiation therapy Regimen Treatment Outcome Oncology Liver Chemotherapy Adjuvant 030220 oncology & carcinogenesis Child Preschool Population study 030211 gastroenterology & hepatology Female Neoplasm Recurrence Local business |
| Zdroj: | Journal of gastrointestinal cancer. 49(4) |
| ISSN: | 1941-6636 |
| Popis: | Hepatoblastoma is the most common liver malignancy in the pediatric age group. The management of hepatoblastoma involves multidisciplinary approach. Patients with hepatoblastoma who underwent liver resection between 2000 and 2013 were analyzed and survival outcomes were studied. The crude incidence rate of hepatoblastoma at the Madras Metropolitan Tumor Registry (MMTR) is 0.4/1,00,000 population per year. Twelve patients underwent liver resection for hepatoblastoma during the study period; this included eight males and four females. The median age at presentation was 1.75 years (Range 5 months to 3 years). The median serum AFP in the study population was 20,000 ng/ml (Range 4.5 to 1,40,000 ng/ml). Three patients had stage I, one patient had stage II, and eight patients had stage III disease as per the PRETEXT staging system. Two patients were categorized as high risk and ten patients were categorized as standard risk. Seven of these patients received two to four cycles of neoadjuvant chemotherapy (PLADO regimen), and one patient received neoadjuvant radiation up to 84 Gy. Major liver resection was performed in nine patients. Nine patients received adjuvant chemotherapy. The most common histological subtype was embryonal type. Microscopic margin was positive in three cases. One patient recurred 7 months after surgery and the site of failure was the lung. The 5-year overall survival of the case series was 91%. The median survival was 120 months. Liver resections can be safely performed in pediatric populations after neoadjuvant treatment. Patients undergoing surgery had good disease control and long-term survival. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink